1 month Pfizer to sell $3 billion stake in Sensodyne maker Haleon Investing.com

   X     

1 month Pfizer Sells 700 Million Haleon Shares for $3 Billion The Wall Street Journal

   X     

1 month Pfizer Sells 700 Million Haleon Shares for $3.05 Billion Yahoo Finance

   X     

1 month Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund Yahoo Finance

   X     

1 month Pfizer to sell 7.7% stake in Haleon for potential $3.1 billion, Bloomberg reports Investing.com

   X     

1 month Pfizer to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunner Yahoo Finance

   X     

1 month Pfizer CEO Albert Bourla: Our 2025 focus is on pipeline YouTube

   X     

1 month Pfizer Inc. (PFE) 43rd Annual J.P. Morgan Healthcare Conference (Transcript) Seeking Alpha

   X     

1 month Pfizer Meets Goal in Non-Muscle Invasive Bladder Cancer Study Zacks

   X     

1 month Pfizer: My Top Play In 2025 Using Dogs Of The Dow Strategy Seeking Alpha

   X     

1 month Pfizer must face lawsuit over diversity fellowship program, US court rules Investing.com

   X     

1 month Pharma Stock Roundup: FDA Updates for JNJ, GSK, PFE, NVO’s Expanded Deal Zacks

   X     

2 months Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note Zacks

   X     

2 months GSK, Pfizer RSV shots must warn about rare paralysis risk Fortune

   X     

2 months Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer Seeking Alpha

   X     

2 months FDA requires GSK and Pfizer vaccines to carry rare side effect warnings Investing.com

   X     

2 months Why Pfizer (PFE) is a Top Value Stock for the Long-Term Zacks

   X     

2 months Is Trending Stock Pfizer Inc. (PFE) a Buy Now? Zacks

   X     

2 months Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1 Fortune

   X     

2 months Pfizer Rises 5.6% in a Month: How Should You Play the Stock? Zacks

   X     

2 months Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More Zacks

   X     

2 months Pfizer: A Step-By-Step Strategy Before Earnings Seeking Alpha

   X     

2 months The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

   X     

2 months The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP Zacks

   X     

2 months Pfizer (PFE) Advances While Market Declines: Some Information for Investors Zacks

   X     

2 months Top Research Reports for Berkshire Hathaway, Home Depot & Pfizer Zacks

   X     

2 months Here’s Why Pfizer (PFE) is a Strong Momentum Stock Zacks

   X     

2 months Pfizer’s 2025 Comeback: What’s Driving Growth Seeking Alpha

   X     

2 months 2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive Fast Company

   X     

2 months Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact MarketWatch

   X     

2 months Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact Yahoo Finance

   X     

2 months Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

   X     

2 months Sangamo Plunges After Pfizer Ends Pact for Hemophilia Drug Yahoo Finance

   X     

2 months Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact Yahoo Finance

   X     

2 months Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership Yahoo Finance

   X     

2 months NIH settlement ‘manageable headwind’ for BioNTech, Pfizer, says Morgan Stanley Yahoo Finance

   X     

2 months 3 Reasons to Buy Pfizer Stock Like There’s No Tomorrow Yahoo Finance

   X     

2 months Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal Investing.com

   X     

2 months SGMO Stock Crashes as Pfizer Ends Deal for Hemophilia Candidate Zacks

   X     

2 months Pfizer ends global collaboration with Sangamo, shares drop 27% Investing.com

   X     

2 months Pfizer: One Of The Next Big AI Winners Seeking Alpha

   X     

2 months Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key Insights Zacks

   X     

2 months Pharma Stock Roundup: NVO’s Obesity Study Failure, FDA Nod to PFE, LLY Zacks

   X     

2 months Pfizer: Why I’m Staying On The Sidelines Seeking Alpha

   X     

2 months Better Income Stock: Pfizer or Altria Group? Yahoo Finance

   X     

2 months Pfizer: Time And Patience Ran Out (Rating Downgrade) Seeking Alpha

   X     

2 months Should Value Investors Buy Pfizer (PFE) Stock? Zacks

   X     

2 months Pfizer’s 2025 ‘Boring’ Outlook Had A Nice Surprise That Was Overlooked Seeking Alpha

   X     

2 months Pharma Stock Roundup: PFE’s 2025 Outlook, MRK & ABBV’s M&A Deals Zacks

   X     

2 months Market Digest: ACN, ATO, OGE, PFE, PNW, JCI, DASH Yahoo Finance

   X